[HTML][HTML] SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines

S Pather, SA Madhi, BJ Cowling, P Moss… - Frontiers in …, 2023 - frontiersin.org
The highly transmissible Omicron (B. 1.1. 529) variant of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) was first detected in late 2021. Initial Omicron waves were …

Need of booster vaccine doses to counteract the emergence of SARS-CoV-2 variants in the context of the Omicron variant and increasing COVID-19 cases: An update

RK Mohapatra, NA El-Shall, R Tiwari… - Human Vaccines & …, 2022 - Taylor & Francis
The emergence of different variants of SARS-CoV-2, including the Omicron (B. 1.1. 529)
variant in November 2021, has resulted in a continuous major health concern at a global …

[HTML][HTML] Omicron BA. 1 and BA. 2 neutralizing activity elicited by a comprehensive panel of human vaccines

JE Bowen, KR Sprouse, AC Walls, IG Mazzitelli… - BioRxiv, 2022 - ncbi.nlm.nih.gov
Abstract The SARS-CoV-2 Omicron variant of concern comprises three sublineages
designated BA. 1, BA. 2, and BA. 3, with BA. 2 steadily replacing the globally dominant BA …

[HTML][HTML] Clinical outcomes associated with SARS-CoV-2 Omicron (B. 1.1. 529) variant and BA. 1/BA. 1.1 or BA. 2 subvariant infection in Southern California

JA Lewnard, VX Hong, MM Patel, R Kahn, M Lipsitch… - Nature medicine, 2022 - nature.com
Epidemiologic surveillance has revealed decoupling of Coronavirus Disease 2019 (COVID-
19) hospitalizations and deaths from case counts after emergence of the Omicron (B. 1.1 …

[HTML][HTML] Different neutralization profiles after primary SARS-CoV-2 Omicron BA. 1 and BA. 2 infections

I Medits, DN Springer, M Graninger, JV Camp… - Frontiers in …, 2022 - frontiersin.org
Background and Methods The SARS-CoV-2 (severe acute respiratory syndrome
coronavirus 2) Omicron (B. 1.1. 529) variant is the antigenically most distinct variant to date …

The relative prevalence of the Omicron variant within SARS-CoV-2 infected cohorts in different countries: a systematic review

A Sarkar, S Omar, A Alshareef, K Fanous… - Human Vaccines & …, 2023 - Taylor & Francis
The Omicron variant of SARS-CoV-2 was detected in October 2021 and exhibited high
transmissibility, immune evasion, and reduced severity when compared to the earlier …

Mutational pattern, impacts and potential preventive strategies of omicron SARS-CoV-2 variant infection

E Chekol Abebe, M Tiruneh G/Medhin… - Infection and Drug …, 2022 - Taylor & Francis
Since the emergence of COVID 19, the authentic SARS-CoV-2 has evolved into a range of
novel variants that are of more global concern. In late November 2021, the Omicron (lineage …

[HTML][HTML] Diminished neutralization responses towards SARS-CoV-2 Omicron VoC after mRNA or vector-based COVID-19 vaccinations

H Jacobsen, M Strengert, H Maaß, MA Ynga Durand… - Scientific reports, 2022 - nature.com
SARS-CoV-2 variants accumulating immune escape mutations provide a significant risk to
vaccine-induced protection against infection. The novel variant of concern (VoC) Omicron …

[HTML][HTML] mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant

WF Garcia-Beltran, KJS Denis, A Hoelzemer, EC Lam… - Cell, 2022 - cell.com
Recent surveillance has revealed the emergence of the SARS-CoV-2 Omicron variant (BA.
1/B. 1.1. 529) harboring up to 36 mutations in spike protein, the target of neutralizing …

SARS‐CoV‐2 Omicron and its current known unknowns: A narrative review

TTB Le, T Vasanthakumaran… - Reviews in Medical …, 2023 - Wiley Online Library
The emergence of the SARS‐CoV‐2 Omicron variant (B. 1.1. 529) has created great global
distress. This variant of concern shows multiple sublineages, importantly B. 1.1. 529.1 (BA …